Brett A. Grimaud - 20 Aug 2026 Form 4 Insider Report for Theravance Biopharma, Inc. (TBPH)

Reporting relationship: SVP, GEN COUNSEL AND SECRETARY
Issuer ticker: TBPH
Reported as of: 20 Aug 2026
Net transaction value: $0
SEC form: 4
Accepted by SEC: 24 Aug 2026, 18:02:45 UTC
Prior SEC filing: 22 May 2026
Source filing: View source filing
Reporting owner signature: /s/ Brett A Grimaud

Key filing fact

Brett A. Grimaud filed Form 4 for Theravance Biopharma, Inc. (TBPH) on 24 Aug 2026.

Key facts

This page summarizes Brett A. Grimaud's Form 4 filing for Theravance Biopharma, Inc. (TBPH).
1 reported transaction and 0 derivative rows are listed below.
Accepted by SEC: 24 Aug 2026, 18:02.

Change

Previous filing in this sequence was filed on 22 May 2026.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001966698 Primary reporting owner

Grimaud Brett A.

Relationship: SVP, GEN COUNSEL AND SECRETARY
Address: C/O THERAVANCE BIOPHARMA US, LLC, 901 GATEWAY BLVD, SOUTH SAN FRANCISCO
Signature: /s/ Brett A Grimaud
Signature date: 24 Aug 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

TBPH transaction

Ordinary Shares

Tax liability

Transaction value
Shares: -7,952
Change %: -2.2%
Price: $16.95^*
Shares after: 355,168
Date: 20 Aug 2026
Ownership: Direct
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

Shares withheld to satisfy tax obligations arising out of the vesting of previously granted restricted stock units. The share withholding transaction was with the issuer and did not involve an open market transaction.